Therefore, in this study we would like to detect the serum expression of these above alarmins (HMGB1, S100B, IL-1α, IL-33, S100A9, and S100A12) in NSV patients and healthy controls, to further investigate their clinical significance in the diagnosis and assessment of disease activity/severity in vitiligo. This evidence concerns the gene S100B and vitiligo.